FDA seeks more patient input

05/16/2013 | MedCityNews.com

The FDA is trying to engage more patients at earlier stages of the agency's decision-making processes, asking for patient input not only on drug approvals but also on clinical trial design, unmet medical needs, and the utility of new drugs and devices. "When it comes down to final decision, we want input on what risk patients are willing to tolerate to get the benefits," said James Valentine, program manager at the FDA Office of Health and Constituent Affairs.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC